That our experimental conditions could successfully elicit hypoxic stress in breast cancer cells was separately verified by assessing the expression profile of HIF1α, an established cellular biomarker of hypoxia (Fig 1a & 1b). This evidence concerns the gene HIF1A and breast cancer.